Ex-McDermott, Dorsey Attys Face Insider Trading Trial

Law360, New York (September 24, 2009, 4:25 PM EDT) -- A former corporate partner at Dorsey & Whitney LLP and a former corporate partner at McDermott Will & Emery LLP have been committed to stand trial at London's Southwark Crown Court on eight counts of insider trading related to Novartis AG's $589 million takeover of drugmaker Neutec Pharma PLC.

Former Dorsey & Whitney partner Andrew Rimmington, former McDermott Will partner Michael McFall and former Neutec Pharma finance director Andrew King were remanded on bail to appear at Southwark Crown Court for a plea and case management...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.